Skye is a California-based biopharmaceutical company that develops and commercializes cannabinoid-based therapeutics for the treatment of glaucoma and a range of diseases.
Business Model:
Revenue: $0
Employees: 2-10
Address: 11250 El Camino Real
City: San Diego
State: CA
Zip: 92130
Country: US
Skye is a California-based biopharmaceutical company that develops and commercializes cannabinoid-based therapeutics for the treatment of glaucoma and a range of diseases.
Contact Phone:
+18584100266
Contact Email:
Listed Exchange:
Other
IPO Date:
12/1/2014
Ticker Symbol:
SKYE
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2020 | Post-IPO Equity | $7M | 6/2014 | Series A | $1.5M | 11/2017 | Post-IPO Equity | $2M | 8/2015 | Post-IPO Equity | $0 |
Midtown Partners Midtown Partners Midtown Partners Midtown Partners |
2/2018 | Private Placement | $1.8M |
Emerald Health Sciences |
4/2015 | Post-IPO Equity | 1 | $625k |
TYLT Ventures TYLT Ventures |
1/2015 | Post-IPO Equity | 1 | $725k |
TYLT Ventures TYLT Ventures |
5/2017 | Post-IPO Equity | 1 | $20M |
SCHNEIDER Brothers SCHNEIDER Brothers SCHNEIDER Brothers SCHNEIDER Brothers |
10/2017 | Equity | $2M | 1/2018 | Equity | $2.4M | 4/2020 | Debt | $116.7k |
City National Bank Small Business Administration |
9/2021 | Post-IPO Equity | $7M | 8/2015 | Post-IPO Equity | 1 | $5M |
Midtown Partners Midtown Partners Midtown Partners Midtown Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|